Cargando…

Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease

INTRODUCTION: Late‐life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship with cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2750 people ≥50 years of age without dementia w...

Descripción completa

Detalles Bibliográficos
Autores principales: Creese, Byron, Arathimos, Ryan, Aarsland, Dag, Ballard, Clive, Brooker, Helen, Hampshire, Adam, Corbett, Anne, Ismail, Zahinoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150165/
https://www.ncbi.nlm.nih.gov/pubmed/37139261
http://dx.doi.org/10.1002/trc2.12386
_version_ 1785035311595651072
author Creese, Byron
Arathimos, Ryan
Aarsland, Dag
Ballard, Clive
Brooker, Helen
Hampshire, Adam
Corbett, Anne
Ismail, Zahinoor
author_facet Creese, Byron
Arathimos, Ryan
Aarsland, Dag
Ballard, Clive
Brooker, Helen
Hampshire, Adam
Corbett, Anne
Ismail, Zahinoor
author_sort Creese, Byron
collection PubMed
description INTRODUCTION: Late‐life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship with cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2750 people ≥50 years of age without dementia were analyzed. Incident cognitive impairment was operationalized using the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and psychosis was rated using the Mild Behavioral Impairment Checklist (henceforth MBI‐psychosis). The whole sample was analyzed before stratification on apolipoprotein E (APOE) ε4 status. RESULTS: In Cox proportional hazards models, MBI‐psychosis had a higher hazard for cognitive impairment relative to the No Psychosis group (hazard ratio [HR]: 3.6, 95% confidence interval [CI]: 2.2–6, p < 0.0001). The hazard for MBI‐psychosis was higher in APOE ε4 carriers and there was an interaction between the two (HR for interaction: 3.4, 95% CI: 1.2–9.8, p = 0.02). DISCUSSION: Psychosis assessment in the MBI framework is associated with incident cognitive impairment in advance of dementia. These symptoms may be particularly important in the context of APOE genotype.
format Online
Article
Text
id pubmed-10150165
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101501652023-05-02 Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease Creese, Byron Arathimos, Ryan Aarsland, Dag Ballard, Clive Brooker, Helen Hampshire, Adam Corbett, Anne Ismail, Zahinoor Alzheimers Dement (N Y) Research Articles INTRODUCTION: Late‐life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship with cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2750 people ≥50 years of age without dementia were analyzed. Incident cognitive impairment was operationalized using the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and psychosis was rated using the Mild Behavioral Impairment Checklist (henceforth MBI‐psychosis). The whole sample was analyzed before stratification on apolipoprotein E (APOE) ε4 status. RESULTS: In Cox proportional hazards models, MBI‐psychosis had a higher hazard for cognitive impairment relative to the No Psychosis group (hazard ratio [HR]: 3.6, 95% confidence interval [CI]: 2.2–6, p < 0.0001). The hazard for MBI‐psychosis was higher in APOE ε4 carriers and there was an interaction between the two (HR for interaction: 3.4, 95% CI: 1.2–9.8, p = 0.02). DISCUSSION: Psychosis assessment in the MBI framework is associated with incident cognitive impairment in advance of dementia. These symptoms may be particularly important in the context of APOE genotype. John Wiley and Sons Inc. 2023-04-30 /pmc/articles/PMC10150165/ /pubmed/37139261 http://dx.doi.org/10.1002/trc2.12386 Text en © 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Creese, Byron
Arathimos, Ryan
Aarsland, Dag
Ballard, Clive
Brooker, Helen
Hampshire, Adam
Corbett, Anne
Ismail, Zahinoor
Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
title Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
title_full Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
title_fullStr Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
title_full_unstemmed Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
title_short Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
title_sort late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for alzheimer's disease
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150165/
https://www.ncbi.nlm.nih.gov/pubmed/37139261
http://dx.doi.org/10.1002/trc2.12386
work_keys_str_mv AT creesebyron latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease
AT arathimosryan latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease
AT aarslanddag latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease
AT ballardclive latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease
AT brookerhelen latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease
AT hampshireadam latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease
AT corbettanne latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease
AT ismailzahinoor latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease